Day: May 7, 2020

STAMFORD, Conn., May 07, 2020 (GLOBE NEWSWIRE) — Independence Holding Company (NYSE: IHC) today reported 2020 first-quarter results.   Financial ResultsNet income attributable to IHC per share was $.29 per share, diluted, or $4,278,000, for the three months ended March 31, 2020 compared to $.58 per share, diluted, or $8,727,000, for the three months ended March 31, 2019.  Net income for this quarter is lower primarily because (i) the 2019 first quarter includes a pre-tax gain of $3.6 million on the sale of an equity method investment and (ii) of expenses incurred in the first quarter of this year related to the ramp up of our senior marketing division.The Company reported revenues of $103,997,000 for the three months ended March 31, 2020 compared to revenues for the three months ended March 31, 2019 of $94,182,000.Chief Executive...

HOUSTON, May 07, 2020 (GLOBE NEWSWIRE) — Penn Virginia Corporation (“Penn Virginia” or the “Company”) (NASDAQ:PVAC) today announced its financial and operational results for the first quarter 2020.Recent Significant HighlightsGenerated net cash provided by operating activities of $72.5 million and free cash flow (“FCF”)(1) of $10.5 million for the first quarter of 2020 and expects to generate significant FCF(1) for 2020;Produced 20,665 barrels of oil per day (“BOPD”) and 26,740 barrels of oil equivalent per day (“BOEPD”) in the first quarter of 2020;Reported net income of $163.1 million, or $10.76 per diluted share, and adjusted net income(2) of $28.6 million, or $1.89 per diluted share, for the first quarter of 2020;Generated adjusted EBITDAX(3) of $78.6 million for the first quarter of 2020;Halted all drilling and completion activity...

TAMPA, FL, May 07, 2020 (GLOBE NEWSWIRE) — Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, announced today that its wholly-owned subsidiary, Integra Pharma Solutions, LLC, has formally withdrawn its Emergency Use Authorization (EUA) application in connection with its partner’s manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit from consideration in response to U.S. Food and Drug Administration (FDA) guidance. The decision to withdraw the EUA application was made after much discussion with its partnered manufacturer. Per FDA guidance, only one EUA application is allowed per manufactured kit product. The EUA process is typically filed by manufacturers and there are specific guidelines that must be adhered to by the manufacturer, one of which includes reporting on test...

Le premier patient a été traité dans l’étude VIITAL™ pivot de phase 3 en cours évaluant l’EB-101 pour le pour l’EBDRDes patients supplémentaires ont reçu des doses dans les études de thérapie génique de phase 1/2 sur le MPS IIIA et le MPS IIIBDes données intermédiaires positives issues des programmes de thérapie génique portant sur le MPS III ont été présentées lors du WORLDSymposium™ ; des résultats actualisés seront présentés lors de l’ASGCT 2020Deux chefs de file du secteur ont été nommés au sein du Conseil d’administration et l’équipe de direction a été renforcéeLa société organisera une conférence téléphonique pour les investisseurs le jeudi 7 mai 2020 à 8 h 30 HNENEW YORK et CLEVELAND, 07 mai 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq : ABEO), leader entièrement intégré de...

Behandlung des ersten Patienten im Rahmen der laufenden zulassungsrelevanten VIITAL™-Phase-III-Studie zur Untersuchung von EB-101 für RDEBWeitere Patienten in den Phase-I/II-Gentherapiestudien für MPS IIIA und MPS IIIB behandeltPositive Interimsdaten aus den MPS III-Gentherapieprogrammen auf dem WORLDSymposium™ vorgestellt; aktualisierte Ergebnisse werden auf dem diesjährigen Meeting der ASGCT präsentiertErnennung von zwei Führungskräften der Branche zu Verwaltungsratsmitgliedern und Stärkung des ManagementteamsUnternehmen führt am Donnerstag, den 7. Mai 2020, um 8:30 Uhr ET eine Investorenkonferenz durchNEW YORK und CLEVELAND, May 07, 2020 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), ein voll integriertes führendes Unternehmen im Bereich Gen- und Zelltherapien, gab heute die Geschäftsergebnisse des ersten Quartals...

EBITDA1 of $37 million on Sales of $480 millionNet Debt to Invested Capital1 of 27%; Liquidity of $431 millionVANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) recorded net earnings in Q1’20 of $6.3 million, or $0.09 per share, compared to net losses of $41.7 million, or $0.62 per share in Q4’19 and $15.3 million, or $0.23 per share in Q1’19.  Adjusted net earnings were $0.7 million in Q1’20 compared to Adjusted net losses of $17.4 million in Q4’19 and $12.7 million in Q1’19.Adjusted EBITDA was $36.6 million on sales of $479.6 million in Q1’20 versus $17.6 million on sales of $456.8 million in Q4’19.Net debt ended the quarter at $322.0 million, or 26.7% of invested capital, resulting in available liquidity of $430.9 million. Effects of COVID-19 and Interfor’s...

NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — Verizon Communications Inc. (NYSE, Nasdaq: VZ) has announced preliminary results of the shareholder vote at its first virtual-only annual meeting today. In light of the public health concerns raised by the COVID-19 pandemic and the related protocols that federal, state and local authorities have implemented, the meeting was held in a virtual-only format.Verizon’s shareholders elected each of Verizon’s nine directors to a one-year term. Shareholders also voted in favor of two management proposals:Approved the compensation of the company’s named executive officers as described in the 2020 proxy statement, andRatified the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm.Four shareholder proposals were defeated: eliminate an investment option...

This press release contains forward-looking information that is based upon assumptions and is subject to risks and uncertainties as indicated in the cautionary note contained within this press releaseTORONTO, May 07, 2020 (GLOBE NEWSWIRE) — DREAM OFFICE REAL ESTATE INVESTMENT TRUST (D.UN-TSX) or (“Dream Office REIT”, the “Trust” or “we”) today announced its financial results for the three months ended March 31, 2020 and provided a business update related to the COVID-19 pandemic.FINANCIAL HIGHLIGHTSSee footnotes at end.See footnotes at end.Net income for the quarter: For the three months ended March 31, 2020, the Trust generated net income of $64.8 million. Included in net income are fair value gains recorded on financial instruments totalling $45.3 million primarily attributed to the revaluation of the subsidiary redeemable units.Diluted...